These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2930684)

  • 21. Biological activity of mutants of human tumour necrosis factor-alpha.
    Kircheis R; Milleck J; Korobko VG; Shingarova LN; Behnke D; Schmidt HE
    Immunology; 1992 Jul; 76(3):433-8. PubMed ID: 1526652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to cytolysis by tumor necrosis factor alpha in malignant gynecological cell lines is associated with the expression of protein(s) that prevent the activation of phospholipase A2 by tumor necrosis factor alpha.
    Mutch DG; Powell CB; Kao MS; Collins JL
    Cancer Res; 1992 Feb; 52(4):866-72. PubMed ID: 1737348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro selection of a cell line for resistance to lysis by tumor necrosis factor-alpha selects for reduced tumorigenicity.
    Patek PQ; Lin Y
    J Immunol; 1991 May; 146(10):3457-61. PubMed ID: 2026874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 overexpression and downregulation of inter-alpha-inhibitor are associated with hyaluronidase enhancement of TNF cytotoxicity in L929 fibroblasts.
    Chang NS; Carey G; Pratt N; Chu E; Ou M
    Cancer Lett; 1998 Sep; 131(1):45-54. PubMed ID: 9839619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extremely high production of thymidine by TNF-susceptible L929 cells.
    Volpe EA
    Cancer Lett; 1995 Mar; 89(2):169-76. PubMed ID: 7889525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-beta-induced matrix proteins inhibit p42/44 MAPK and JNK activation and suppress TNF-mediated IkappaBalpha degradation and NF-kappaB nuclear translocation in L929 fibroblasts.
    Chang NS
    Biochem Biophys Res Commun; 2000 Jan; 267(1):194-200. PubMed ID: 10623598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase of MnSOD expression and decrease of JNK activity determine the TNF sensitivity in bcl2-transfected L929 cells.
    Kim YH; Kim SS
    Cytokine; 1999 Apr; 11(4):274-81. PubMed ID: 10328866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modes of L929 cell death induced by TNF-alpha and other cytotoxic agents.
    Humphreys DT; Wilson MR
    Cytokine; 1999 Oct; 11(10):773-82. PubMed ID: 10525316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance of Ha-ras oncogene-induced progressor tumor variants to tumor necrosis factor and interferon-gamma.
    Fernandez A; Chen PW; Aggarwal BB; Ananthaswamy HN
    Lymphokine Cytokine Res; 1992 Apr; 11(2):79-85. PubMed ID: 1581420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Docosahexaenoic acid enrichment can reduce L929 cell necrosis induced by tumor necrosis factor.
    Kishida E; Tajiri M; Masuzawa Y
    Biochim Biophys Acta; 2006 Apr; 1761(4):454-62. PubMed ID: 16698313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of TNFalpha and TNFbeta cytolytic mechanisms in human ovarian and cervical carcinoma cell lines.
    Powell CB; Scott JH; Collins JL
    Gynecol Oncol; 1998 Nov; 71(2):258-65. PubMed ID: 9826469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adenylate cyclase activator forskolin partially protects L929 cells against tumour necrosis factor-alpha-mediated cytotoxicity via a cAMP-independent mechanism.
    Uboldi AD; Savage N
    Cytokine; 2002 Sep; 19(5):250-8. PubMed ID: 12393172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct evidence for an intracellular role for tumor necrosis factor-alpha 1. Microinjection of tumor necrosis factor kills target cells.
    Smith MR; Munger WE; Kung HF; Takacs L; Durum SK
    J Immunol; 1990 Jan; 144(1):162-9. PubMed ID: 2153163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of enhancing antibodies on TNF interactions with its specific receptor: consequences for in vitro TNF antiviral activity.
    Lidbury BA; Rathjen DA; Ramshaw IA; Cowden WB
    Biotechnol Ther; 1994; 5(1-2):27-45. PubMed ID: 7703831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum protease inhibitor abrogation of Newcastle disease virus enhancement of cytolysis by recombinant tumor necrosis factors alpha and beta.
    Rood PA; Lorence RM; Kelley KW
    J Natl Cancer Inst; 1990 Feb; 82(3):213-7. PubMed ID: 2296051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IkappaBalpha is essential for maintaining basal c-Jun N-terminal kinase (JNK) activation and regulating JNK-mediated resistance to tumor necrosis factor cytotoxicity in L929 cells.
    Chang NS
    Biochem Biophys Res Commun; 1999 Sep; 263(1):107-12. PubMed ID: 10486261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF.
    Vercammen D; Vandenabeele P; Declercq W; Van de Craen M; Grooten J; Fiers W
    Cytokine; 1995 Jul; 7(5):463-70. PubMed ID: 7578985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor induces activation of mitochondrial succinate dehydrogenase.
    Levrat C; Larrick JW; Wright SC
    Life Sci; 1991; 49(23):1731-7. PubMed ID: 1943475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between multidrug resistance and tumor necrosis factor resistance in an EL4 cell line model.
    Ujhazy P; Chen YF; Fredericks W; Ho RL; Mihich E; Baker RM; Ehrke MJ
    Cancer Commun; 1990; 2(5):181-8. PubMed ID: 1973358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo.
    Beyaert R; Vanhaesebroeck B; Suffys P; Van Roy F; Fiers W
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9494-8. PubMed ID: 2556714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.